베인은 홈페이지 기능 및 성능 개선을 위해 쿠키를 사용합니다. 이와 관련된 더 많은 정보는 개인정보 메뉴에서 확인하실 수 있습니다. 이 웹사이트를 계속 사용하시면 쿠키 사용에 동의하신 것으로 간주됩니다. 

BioPharma Dive

11 biopharma execs & experts look back on 2015: A record year for record-breaking

11 biopharma execs & experts look back on 2015: A record year for record-breaking

  • 2015년12월22일
  • 읽기 소요시간

BioPharma Dive

11 biopharma execs & experts look back on 2015: A record year for record-breaking

BioPharma Dive asked top thought leaders to share what they considered to be the top biopharma "game-changers" of 2015. "A major game-changer in 2015 was increasing price pressure on prescription drugs in the U.S. market coming from a rapidly consolidating customer case (payers/PBMs, providers and channel)," said Ashish Singh, the leader of Bain & Company's Global Healthcare practice. "This trend is now starting to endanger the economic lifeblood of the global pharmaceutical industry—the premium price reimbursement in the U.S."